About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t ...
Groupama Asset Management cut its stake in Amgen by nearly 15% in Q4, selling off over 3,000 shares. At quarter’s end, their ...
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now
President Donald Trump’s exemption of pharmaceuticals from “reciprocal” tariffs limited the declines of biopharma stocks as ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results